Vascular Endothelial Growth Factor Insertion/Deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy

1. Potra RA, Kacso MI, Bondor CI, Gherman-Căprioară M. The predictive value of serum intercellular adhesion molecule 1 for the progression of diabetic kidney disease in type 2 diabetic patients. Rev Romana Med Lab. 2013;21(4):399-406. DOI: 10.2478/rrlm-2013-004510.2478/rrlm-2013-0045Search in Google Scholar

2. Michael J. Fowler Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes. 2008;26(2):77-82. DOI: 10.2337/diaclin.26.2.7710.2337/diaclin.26.2.77Search in Google Scholar

3. Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther. 2010;12(10):755-61. DOI: 10.1089/dia.2010.006910.1089/dia.2010.006920818974Search in Google Scholar

4. Abbott CA, Chaturvedi N, Malik RA, Salgami E, Yates AP, Pemberton PW, et al. Explanations for the lower rates of diabetic neuropathy in Indian Asians Versus Europeans. Diabetes Care. 2010;33(6):1325-30. DOI: 10.2337/dc09-206710.2337/dc09-2067287544820215455Search in Google Scholar

5. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-5. DOI: 10.1038/359843a010.1038/359843a01279431Search in Google Scholar

6. Zhang X, Bao S, Hambly BD, Gillies MC. Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy. Int J Biochem Cell Biol. 2009;41(12):2368-71. DOI: 10.1016/j.biocel.2009.07.01110.1016/j.biocel.2009.07.01119646547Search in Google Scholar

7. Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organogenesis. 2010;6(2):107-14.DOI: 10.4161/org.6.2.1168710.4161/org.6.2.11687290181420885857Search in Google Scholar

8. Ropper AH, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, et al. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol. 2009;65(4):386-93. DOI: 10.1002/ana.2167510.1002/ana.21675470901219399887Search in Google Scholar

9. Isner JM. Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle. J Clin Invest. 2000;106:615-9. DOI: 10.1172/ JCI1096110.1172/JCI1096138129510974011Search in Google Scholar

10. Giacca M, Zacchigna S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 2012;19(6):622-9. DOI: 10.1038/gt.2012.1710.1038/gt.2012.1722378343Search in Google Scholar

11. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.Diabetes. 1999; 48:1899-906. DOI: 10.2337/diabetes.48.10.189910.2337/diabetes.48.10.1899Search in Google Scholar

12. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000;77:S113-9. DOI: 10.1046/j.1523-1755.2000.07718.x10.1046/j.1523-1755.2000.07718.xSearch in Google Scholar

13. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst. 2004;9:26-53. DOI: 10.1111/j.1085-9489.2004.09105.x10.1111/j.1085-9489.2004.09105.xSearch in Google Scholar

14. Tavakkoly-Bazzaz J, Amoli MM, Pravica V, Chandrasecaran R, Boulton AJ, Larijani B, et al. VEGF gene polymorphism association with diabetic neuropathy.Mol Biol Rep. 2010;37:3625-30. DOI: 10.1007/ s11033-010-0013-610.1007/s11033-010-0013-6Search in Google Scholar

15. Quattrini C, Jeziorska M, Boulton AJ, Malik RA. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care. 2008;31(1):140-5. DOI: 10.2337/dc07-155610.2337/dc07-1556Search in Google Scholar

16. Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetic patients.Nephrol Dial Transplant. 2007;22(3):827-32.DOI: 10.1093/ndt/gfl64110.1093/ndt/gfl641Search in Google Scholar

17. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW.Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res. 2003;63(4):812-6.Search in Google Scholar

18. He Y, Ni J, Chen S, Jiang Y, Jia S, Gao Y. The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese. DNA Cell Biol. 2010;29(7):393-6. DOI: 10.1089/dna.2009.101510.1089/dna.2009.1015Search in Google Scholar

19. Ropper AH1, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, et al. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol. 2009;65(4):386-93. DOI: 10.1002/ana.2167510.1002/ana.21675Search in Google Scholar

20. Deguchi T, Hashiguchi T, Horinouchi S, Uto T, Oku H, Kimura K, et al. Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabetic Medicine. 2009;26(3):247-52. DOI: 10.1111/j.1464-5491.2009.02680.x10.1111/j.1464-5491.2009.02680.xSearch in Google Scholar

21. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.J Diabetes Complications. 2003;17(1):1-6. DOI: 10.1016/S1056-8727(02)00181-210.1016/S1056-8727(02)00181-2Search in Google Scholar

22. Kacso MI, Trifa PA, Popp AR, Bondor IC, Farcas FM, Lenghel RA, et al. Adiponectin gene 45T>G polymorphism is not associated to plasma adiponectin in a cohort of patients with type 2 diabetes from Romania. Rev Romana Med Lab. 2012;20(1):73-9.Search in Google Scholar

23. Moldovan R, Kacsò I, Gherman-Căprioară M. Relationship between soluble intercellular adhesion molecule 1 and clinically manifest cardiovascular disease in diabetic chronic hemodialysis patients. Rev Romana Med Lab. 2012;20(4):353-61. Search in Google Scholar